5. Results of treatment of cerebral hemorrhage at 8 hospitals in the North - North Central of Vietnam
Main Article Content
Abstract
The objective of this study was to report clinical characteristics, treatment result and indicate the factors affecting mRS 0-2 and mortality after 90 days of treatment in patients with cerebral hemorrhage at stroke unit/department in the North and North Central, Vietnam. As the result, 433 patients were selected from August 1, 2022 to August 31, 2022 from 8 stroke centers. Patients who were hospitalized at the stroke center of Bach Mai Hospital accounted for the largest proportion with 56.4%. Overall, male accounted for 66.1%,The average age was 60.71 ± 15.41years old- patients of forty-five year old and under accounted for 13.8% After 90 days of treatment, themortality rate was 21%, patients with mRS 0-2 was 46%. NIHSS score and bleeding site were factors influencing mortality and mRS 0-2 after 90 days of treatment.
Article Details
Keywords
Cerebral hemorrhage, treatment result, prognostic factor
References
2. Garg R, Biller J. Recent advances in spontaneous intracerebral hemorrhage. F1000Res. 2019; 8.
3. Shen J, Guo F, Yang P, Xu F. Influence of hypertension classification on hypertensive intracerebral hemorrhage location. J Clin Hypertens (Greenwich). 2021; 23(11): 1992-9.
4. Mai DT, Phan H, Hoang VM, Nguyen TD, Phan HQ, Vuong XT, et al. Treatment of stroke patients in the context of the COVID-19 pandemic: Lessons learnt from a major stroke center in Vietnam. J Glob Health. 2021; 11: 03092.
5. Tatlisumak T, Cucchiara B, Kuroda S, Kasner SE, Putaala J. Nontraumatic intracerebral haemorrhage in young adults. Nat Rev Neurol. 2018; 14(4): 237-50.
6. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019; 50(12).
7. Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022; 53(7): e282-e361.
8. Toyoda K, Yoshimura S, Nakai M, Koga M, Sasahara Y, Sonoda K, et al. Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic Strokes. JAMA Neurol. 2022; 79(1): 61-9.
9. Namale G, Kamacooko O, Makhoba A, Mugabi T, Ndagire M, Ssanyu P, et al. Predictors of 30-day and 90-day mortality among hemorrhagic and ischemic stroke patients in urban Uganda: a prospective hospital-based cohort study. BMC Cardiovasc Disord. 2020; 20(1): 442.
10. Slattery JM, Hankey GJ. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol. 1992; 32(2): 225-6.
11. Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017; 389(10069): 603-11.
12. Mai DT, Phuong DV, Dung NT, et al. Sex disparity in stroke outcomes in a multicenter prospective stroke registry in Viet Nam. International Journal of Stroke, 2023. doi.org/10.1177/17474930231177893.